Aces Health aims to revolutionize clinical trials with its cutting-edge platform, enabling automated patient engagement and data collection. Founded in 2014 and headquartered in Atlanta, Georgia, the company has gained traction with its emphasis on enhancing adherence and efficiency in drug development. Aces Health's platform offers advanced tools to address medical nonadherence, ensuring consistent and motivated patient participation. The integration of over 200 wearable sensors, smart devices, and thousands of EMR systems into its main app platform showcases the company's commitment to leveraging technology for streamlined clinical research. This approach not only saves substantial time and resources but also proves instrumental in reducing overall costs in the continuum of care. The company's recent Seed Round investment at 01 January 2017 was led by Krillion Ventures and Miami Children’s Health Ventures, reflecting the confidence of prominent investors in Aces Health's potential to make a significant impact in the healthcare industry. With its innovative solutions and strategic partnerships, Aces Health is poised to make waves in the clinical trial space, driving efficiency and efficacy in drug development.
No recent news or press coverage available for Aces Health.